Carbylan Therapeutics Lands $5,000,000 New Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=763a23e0-6c95-488a-99dd-f4d2e6253e5f
Date
10/14/2014
Company Name
Carbylan Therapeutics
Mailing Address
3181 Porter Drive Palo Alto, CA 94304 USA
Company Description
Carbylan Therapeutics develops and markets bioresponsive medical products to enhance healing, provide better surgical outcomes and improve patients’ quality of life. Carbylan is committed to quality in all areas of its business by complying with regulatory requirements and improving the effectiveness of its quality system.
Website
http://www.carbylan.com
Transaction Type
Debt
Transaction Amount
$5,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
M&A Terms
Venture Investor